• News & Events
  • News
  • Tübingen-based start-up Atriva Therapeutics GmbH develops innovative flu drug

Interview with ATRIVA CEO during BIO-Europe Spring(R) 2017

During the BIO-Europe Spring (R) event 2017, ATRIVA's CEO Dr. Rainer Lichtenberger was interviewed about the aims and future of ATRIVA.

You can watch the video on the newspage by clicking on it!

Media Coverage

 

Events & Presentations

Please note that, due to the current coronavirus crisis, many conferences have been canceled or postponed.

  • September 21-24, 2020 - BioPharm America Digital. Dr. Björn Cochlovius, VP Business Development, will represent the Company and be available for networking and one-on-one meetings.
  • October 26-29, 2020 - BIO-Europe Digital.

Feel free to contact us any time.

Address

Atriva Therapeutics GmbH
Eisenbahnstr. 1, 72072 Tübingen

+49 (0)7071 8597673
info@atriva-therapeutics.com

LinkedIn
Twitter

In order to be able to design our website in the best possible way and to continuously improve it, we are using cookies. By continuing to use our website, you permit the use of cookies. More information can be found in our data protection rules.